EYE nova eye medical limited

It seems some are confused with how operating leverage works....

  1. 18,554 Posts.
    lightbulb Created with Sketch. 5276
    It seems some are confused with how operating leverage works. The thing is, for quality companies like EYE, sales tend to increase by a lot more than what you spent for that increase to happen. This is evident in the very strong returns generated per sales rep, and in the recent financial data.


    • From FY23 to FY24 global sales increased by $6.3m
    • From FY23 to FY24 global operating expenditure increased by only $1.5m
    • Additionally, from FY23 to FY24 the gross margin also improved from 68% to 72%.


    As is evident, $6.3m increase in sales only required expenditure of $1.5m. This gap will continue to widen as scale continues to increase, and is why profitability in the near term is highly likely. It is also why attempting to assume that the net loss / profit for the current half will be the same as the prior half is also fraught with error. The company has proved it can grow sales with minimal added expenditure, and that is why we have seen such a substantial improvement in the bottom-line performance, and is why predictors of capital raises continue to be proved wrong with each announcement released.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
14.5¢
Change
0.005(3.57%)
Mkt cap ! $41.28M
Open High Low Value Volume
14.0¢ 14.5¢ 13.5¢ $50.15K 358.6K

Buyers (Bids)

No. Vol. Price($)
3 57340 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
14.5¢ 325518 2
View Market Depth
Last trade - 16.10pm 08/08/2025 (20 minute delay) ?
EYE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.